#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma Hyperadrenocorticism Nasopharyngeal cancer Ataxia telangiectasia Muscular dystrophy Cutaneous calcification Hereditary angioedema with C1 esterase inhibitor deficiency Crigler-Najjar syndrome Lymphoma Penile cancer Hepatitis D Angiosarcoma recurrent Oesophageal squamous cell carcinoma stage III Meningococcal immunisation Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Alexander disease – Treatment Malignant fibrous histiocytoma – Life with Disease Myelodysplastic syndrome – Diagnostics Piriformis syndrome – Life with Disease Richter’s syndrome Haemolytic uraemic syndrome – Life with Disease Gaucher’s disease type III – Life with Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease Proteus syndrome – Treatment Pemphigus – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Secale Cereale Autologous Chondrocytes Idursulfase Isis 696844 Imiglucerase Phleum Pratense (225) Epinephrine Altizide VERCIRNON Setanaxib Mps-213 Nesolicaftor Arsenic Trioxide Olmesartan Medoxomil Azd5004 Temsirolimus Mps-102 Phenobarbital Fenofibrate Micronised ZIGAKIBART More therapies…

    Learn about Your Condition

    Left ventricular dysfunction Cardiac sarcoidosis Dementia Iron deficiency anaemia Dyslipidaemia Ovarian epithelial cancer Biliary neoplasm Pyelonephritis Oropharyngeal cancer recurrent Pancreatitis chronic Bacterial infection Anal abscess Insomnia Biliary tract operation Type V hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer

  • Study on Amcenestrant Alone and with Drug Combination for Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Amcenestrant
    • Abemaciclib
    • Palbociclib
    Belgium Spain

  • Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Hormone receptor negative HER2 positive breast cancer
    • Oestrogen receptor gene overexpression
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Study on Early Breast Cancer Treatment with Palbociclib, Tamoxifen, and Exemestane for Patients with Estrogen Receptor Positive Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    Sweden

  • Study on the Impact of DPYD Gene Test on the Safety and Efficacy of Fluorouracil, Capecitabine, and Tegafur in Finnish Patients with Breast or Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Breast cancer
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Finland

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Abemaciclib
    • Letrozole
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Triple negative breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • ZELENECTIDE PEVEDOTIN
    Belgium France Italy Spain
Previous Page
1 … 25 26 27 28
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!